Adagio Medical to Participate in Annual Needham Conference

The medical device company will showcase its catheter ablation technologies at the virtual event.

Apr. 6, 2026 at 5:42pm

A sleek, polished medical device made of premium materials, arranged elegantly against a clean, monochromatic background, conceptually representing Adagio Medical's innovative cardiac ablation technologies.Adagio Medical's cutting-edge cardiac ablation device takes center stage at the prestigious Needham investment conference.Laguna Hills Today

Adagio Medical Holdings, Inc., a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, announced that it will participate in the 25th Annual Needham Virtual Conference. The conference will provide Adagio an opportunity to showcase its innovative medical devices to investors and industry professionals.

Why it matters

Adagio's participation in the prestigious Needham conference highlights the company's continued growth and leadership in the cardiac ablation device market. As a public company, Adagio's presence at this event allows it to connect with the investment community and raise awareness of its innovative technologies.

The details

Adagio Medical, a Nasdaq-listed company, develops advanced catheter ablation technologies used to treat cardiac arrhythmias. The company's participation in the 25th Annual Needham Virtual Conference will give it a platform to present its product portfolio and business strategy to a wide audience of investors, analysts, and industry peers.

  • The 25th Annual Needham Virtual Conference will take place on April 11-14, 2026.

The players

Adagio Medical Holdings, Inc.

A leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias.

Got photos? Submit your photos here. ›

What’s next

Adagio's participation in the Needham conference is expected to generate increased investor interest and potentially lead to new business opportunities for the company.

The takeaway

Adagio's presence at the prestigious Needham conference underscores its position as a leader in the cardiac ablation device market and its commitment to showcasing its innovative technologies to the investment community.